Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings

Vaccine

Volumn 27, Issue 44, 2009, Pages 6203-6209

  Biellik, Robin ^a   Levin, Carol ^b   Mugisha, Emmanuel ^c   LaMontagne, D Scott ^b   Bingham, Allison ^b   Kaipilyawar, Satish ^d   Gandhi, Sanjay ^e  

^a PATH ^*  (Switzerland)

^b PATH   (United States)

^c PATH   (Uganda)

^d PATH   (India)

^e PATH   (India)

Author keywords

Health system; HPV vaccine; Vaccine delivery

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES RUBELLA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; TETANUS TOXOID; TYPHOID VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COOPERATION; DESCRIPTIVE RESEARCH; DRUG COST; FEASIBILITY STUDY; FEMALE; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INDIA; INFECTION PREVENTION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; NONPROBABILITY SAMPLE; PERU; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RESOURCE ALLOCATION; UGANDA; UTERINE CERVIX CANCER; VIET NAM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INDIA; INFANT; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PERU; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; UGANDA; UTERINE CERVICAL NEOPLASMS; VIETNAM;

EID: 70349972024     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.003     Document Type: Article

References (34)

1. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 9447 (2004) 1757-1765
2. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 5 (2005) 271-278
3. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmeron J., Wheeler C.M., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 9580 (2007) 2161-2170
4. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 19 (2007) 1915-1927
5. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S26-S34
6. Castellsague X., Sanjose S., Aguado T., Louie K.S., Bruni L., Munoz J., et al. HPV and cervical cancer in the world 2007 report. Section I: continents and regions. Vaccine 25 Suppl. 3 (2007) C1-C26
7. World Health Organization, and United Nations Population Fund. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries (2006), World Health Organization, Geneva
8. Department of Health. HPV vaccine recommended for NHS immunization programme. Available at: http://nds.coi.gov.uk/environment/fullDetail.asp?ReleaseID=325799&Ne wsAreaID=2&NavigatedFromDepartment-True [accessed 15.08.08].
9. Agosti J.M., and Goldie S.J. Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med 356 19 (2007) 1908-1910
10. Kane M.A., Sherris J., Coursaget P., Aguado T., and Cutts F. Chapter 15: HPV vaccine use in the developing world. Vaccine 24 Suppl. 3 (2006) S132-S139
11. World Health Organization Department of Immunization, Vaccines and Biologicals. Vaccine introduction guidelines. Adding a vaccine to a national immunization programme: decision and implementation (2005), World Health Organization, Geneva
12. Green L.W., and Kreuter M.W. Health program planning: an educational and ecological approach (2005), McGraw-Hill, New York
13. Wittet S. Cervical cancer vaccine project [fact sheet] (2006), PATH, Seattle
14. Bingham A., Janmohamed A., Bartolini R., Creed-Kanashiro H., Katahoire A., Khan I., et al. An approach to formative research in HPV vaccine introduction planning in low-resource settings. Open Vaccine J 2 (2009) 1-16
15. PATH, National AIDS Research Institute (NARI). Assessing introduction of HPV vaccine in India: phase I formative study (2008), PATH, NARI, New Delhi
16. Instituto de Investigación Nutricional (IIN). Strategies for the introduction of the human papilloma virus (HPV) vaccine for prevention of cervical cancer: formative-qualitative study in Peru (2007), IIN, Lima
17. Instituto de Investigación Nutricional (IIN). Study for the introduction of HPV vaccine in Peru, activity 1: mapping the national immunization strategy (2007), IIN, Lima
18. Katahoire A., Jitta J., Arube-Wani J., Kivumbi G., Murokora D., Siu G., et al. Formative research report: an assessment of the readiness for introduction of a cervical cancer vaccine in Uganda (2008), Child Health and Development Centre, Kampala
19. National Institute of Hygiene and Epidemiology (NIHE), PATH. Evaluation of health system and school health program for HPV vaccine introduction in Vietnam (2008), NIHE, PATH, Hanoi
20. MacQueen K.M., McLellan-Lemal E., Barthalow K., and Milstein B. Team-based codebook development: structure, process, and agreement. In: Guest G., and MacQueen K.M. (Eds). Handbook for team-based qualitative research (2008), AltaMira, Lanham 119-136
21. Katahoire A., Jitta J., Kivumbi G., Murokora D., Arube Wani J., Siu G., et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 12 3 (2008) 159-172
22. Menezes L, Jacob M, Gandhi S, Kaipilyawar S, Patki M, Bingham A, et al. Developing an evidence base for cervical cancer vaccine introduction, planning and implementation in India. Indian J Med Res 2009; in press.
23. Crabtree B.F., and Miller W.L. Doing qualitative research (1992), Sage Publications, Newbury Park
24. Miles M.B., and Huberman A.M. Qualitative data analysis: an expanded sourcebook (1994), Sage Publications, Thousand Oaks
25. Lydon P. Immunization financing analysis: a look across 50 countries (2006), World Health Organization, Geneva
26. World Health Organization. Training for mid-level managers. 1. Cold chain, vaccines and safe-injection equipment management (2008), World Health Organization, Geneva
27. United States Agency for International Development. Immunization essentials: a practical field guide (2003), United States Agency for International Development, Washington, DC
28. United Nations Educational Scientific and Cultural Organization. Education for all by 2015: will we make it? (2007), United Nations Educational Scientific and Cultural Organization, Paris
29. Brabin L., Greenberg D.P., Hessel L., Hyer R., Ivanoff B., and Van Damme P. Current issues in adolescent immunization. Vaccine 26 33 (2008) 4120-4134
30. Paavonen J., and Lehtinen M. Introducing human papillomavirus vaccines-questions remain. Ann Med 40 3 (2008) 162-166
31. Bingham A., Drake J.K., and LaMontagne D.S. Sociocultural issues in the introduction of human papillomavirus vaccines in low-resource settings. Arch Pediatr Adolesc Med 163 5 (2009) 455-461
32. Brabin L., Roberts S.A., Stretch R., Baxter D., Chambers G., Kitchener H., et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 336 7652 (2008) 1056-1058
33. Sherris J., Friedman A., Wittet S., Davies P., Steben M., and Saraiya M. Chapter 25: education, training, and communication for HPV vaccines. Vaccine 24 Suppl. 3 (2006) S210-S218
34. Ryan G., and Bernard H. Techniques to identify themes. Field Methods 15 1 (2003) 85-109